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Abstract
Background: Arthropod-borne diseases are some of the most rapidly spreading diseases. Reducing the vector
population is currently the only effective way to reduce case numbers. Central metabolic pathways are potential
targets to control vector populations, but have not been well explored to this aim. The information available on
energy metabolism, as a way to control lifespan and dispersion through flight of dipteran vectors, is inadequate.
Methods: Phosphofructokinase (PFK) activity was measured in the presence of both of its substrates, fructose-6-
phosphate (F6P) and ATP, as well as some allosteric effectors: Fructose- 2,6 – bisphosphate (F2, 6BP), citrate and AMP.
Aedes aegypti phosphofructokinase sequence (AaPFK) was aligned with many other insects and also vertebrate
sequences. A 3D AaPFK model was produced and docking experiments were performed with AMP and citrate.
Results: The kinetic parameters of AaPFK were determined for both substrates: F6P (V = 4.47 ± 0.15 μmol of F1, 6BP/
min, K0.5 = 1.48 ± 0.22 mM) and ATP (V = 4.73 ± 0.57 μmol of F1, 6BP/min, K0.5 = 0.43 ± 0.10 mM). F2,6P was a powerful
activator of AaPFK, even at low ATP concentrations. AaPFK inhibition by ATP was not enhanced by citrate, consistent
with observations in other insects. After examining the sequence alignment of insect and non-insect PFKs, the
hypothesis is that a modification of the citrate binding site is responsible for this unique behavior. AMP, a well-known
positive effector of PFK, was not capable of reverting ATP inhibition. Aedes, Anopheles and Culex are dengue, malaria
and filariasis vectors, respectively, and are shown to have this distinct characteristic in phosphofructokinase control.
The alignment of several insect PFKs suggested a difference in the AMP binding site and a significant change in local
charges, which introduces a highly negative charge in this part of the protein, making the binding of AMP unlikely. This
hypothesis was supported by 3D modeling of PFK with AMP docking, which suggested that the AMP molecule binds
in a reverse orientation due to the electrostatic environment. The present findings imply a potential new way to
control PFK activity and are a unique feature of these Diptera.
Conclusions: The present findings provide the first molecular explanation for citrate insensitivity in insect PFKs, as well
as demonstrating for the first time AMP insensitivity in dipterans. It also identified a potential target for novel
insecticides for the control of arthropod-borne diseases.
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Background
Glycolysis is the most conserved metabolic pathway and
it is found in almost all forms of life. It has ten catalysed
reactions to the conversion of glucose to pyruvate. The
flow rate of this pathway is regulated by the substrates
availability and the allosteric control of the enzymes that
catalyse reactions irreversible in vivo, which are hexoki-
nase (EC: 2.7.1.1), phosphofructokinase (EC: 2.7.1.11)
and pyruvate kinase (EC: 2.7.1.40). Because of PFK’s
important role as a regulatory enzyme of this pathway
its properties have been the target of study in several
organisms.
Since 1984, it has been known that eukaryotic phos-
phofructokinase (PFK, EC 12.7.1.11) is more than twice
the size of bacterial PFK [1]. It was previously proposed
that this is a result of a tandem gene duplication
followed by fusion. It was also suggested that the cata-
lytic site of the new enzyme remained in the amino ter-
minal segment. However, the corresponding site in the
carboxylic segment of the new protein evolved to be-
come the effector-binding site. Site directed mutagenesis
studies, and other techniques seeking to confirm this hy-
pothesis, have been published and the evidence support-
ing it is readily available [2–5].
In most organisms, PFK is inhibited by physiological
concentrations of one of its substrates, ATP. Thus, PFK
activity achieves a significant rate only when the inhibi-
tory effect of ATP is counteracted by at least one of
PFK’s several activators. In vertebrates ADP, AMP and
F2, 6P are the most common PFK activators [3]. In
addition to ATP, citrate also inhibits PFK. Newsholme
and co-workers [6] investigated the effect of citrate on
PFK activity in muscle homogenates from nine insects
and in the cerebral ganglion of the locust. Citrate does
not inhibit PFK in any of these organisms. Other investi-
gations have confirmed the absence of citrate inhibition
in insects [7, 8], but no other distinguishing regulatory
features of insect PFK has been demonstrated. Although
dipterans are of major importance in epidemiology, no
research on the regulatory properties of PFK from any
flight vector has been published to date.
Aedes aegypti is the vector of dengue, the most rapidly
spreading vector borne disease, as well of many other ar-
boviruses like Chikungunya, Yellow fever virus and Zika
virus. There are an estimated 50 million dengue infec-
tions annually and approximately 2.5 billion people live
in dengue endemic countries. There are currently no
dengue-specific drugs nor well tested vaccines against
this disease [9]. Reducing the vector population is cur-
rently the only effective way to reduce case numbers and
consequent fatality rates. However, insect resistance to
the insecticides that are currently available is hampering
this effort. Thus, it would be of great epidemiological
significance to find ways of targeting diverse aspects of
vector biology in order to contain the spread of Dengue.
Dengue virus takes 8 - 12 days to propagate inside the
mosquito and to reach the salivary glands [10]. Feeding
on carbohydrates after a blood meal significantly in-
creases the life span and dispersion of female mosqui-
toes [11, 12]. Therefore, the study of sugar utilization by
mosquitoes should no longer be neglected. Only the fe-
male is capable of feeding on blood and is therefore a
disease vector. This, together with the once accepted hy-
pothesis that, in nature, female mosquitoes rarely feed
on sugar [13], may explain the lack of available studies
about the glycolytic pathway in this insect. Nevertheless
it was shown [14] that this hypothesis was based on an
inaccurate method used to quantify carbohydrates in
field-captured mosquitoes. Measurable amounts of fruc-
tose, an indication of the ingestion of plant sugars by the
mosquito, in Brazilian field-captured mosquitoes were
found [14]. To gain information on the control of the
glycolytic pathway in A. aegypti and, perhaps, to find a
new target for controlling mosquito populations or lon-
gevity, this study investigated the kinetic properties of
PFK, which is one of the enzymes that physiologically
regulates glycolytic flux in all of the organisms studied
to date. Unique patterns of citrate and AMP insensitivity
in this insect group were found. Herein, molecular ex-
planations are proposed, based on molecular 3D model-
ing and docking experiments, for the relevance of such
findings in Diptera and their potential use as novel tar-
gets to block disease transmission.
Methods
Ethics Statement
All animal care and experimental protocols were con-
ducted in accordance with the guidelines of the institu-
tional care and use committee (Comissão de Avaliação
do Uso de Animais em Pesquisa da Universidade Federal
do Rio de Janeiro, CAUAP-UFRJ) and the NIH Guide
for the Care and Use of Laboratory Animals (ISBN 0-
309-05377-3). The protocols received registry number
115/13 from the Animal Ethics Committee (Comissão
de Ética no Uso de Animais, CEUA).
Mosquito Rearing and Sample Preparation
A. aegypti (Red Eye strain) were reared at 28 ± 2 °C and
80 ± 5 % humidity on a 12 h light-dark cycle under
standard laboratory conditions. Culex quinquefasciatus
and Anopheles aquasalis mosquitoes were kindly pro-
vided by Dr. Denise Valle from the Laboratory of Physi-
ology and Control of Arthropod Vectors/Oswaldo Cruz
Foundation. Drosophila melanogaster flies were provided
by Dr. Blanche Christine Pires de Bitner-Mathé Leal
from the Laboratory of Population Genetics of Drosoph-
ila, Federal University of Rio de Janeiro. Groups of 10
insects were homogenized in 150 μL of 50 mM Tris-HCl
Nunes et al. Parasites & Vectors  (2016) 9:107 Page 2 of 11
pH 7.4, 0.15 M NaCl. The extract was centrifuged at
130,000 x g, at 30 psi, for 60 min (Beckman Airfuge,
Beckman Instruments Inc., CA, USA). An aliquot of the
supernatant (100 μL) was collected and used for enzyme
activity measurements.
Phosphofructokinase activity
PFK activity was measured as described previously [15,
16]. The reaction media contained 50 mM Tris-HCl
pH 7.4, 1.8 mM (NH4)2SO4, 2 mM NADH, 5 mM
MgCl2 and, unless otherwise stated, 1 mM ATP and F6P,
as well as the coupled enzymes aldolase (4 U/mL), triose
phosphate isomerase (4 U/mL) and α-glycerophosphate
dehydrogenase (4 U/mL). The reaction was started by
the addition of 10 μL of homogenate, which contained
approximately 10 μg of protein, to the reaction mixture.
The oxidation of NADH was monitored spectrophoto-
metrically for 60 min at 340 nm, and the linear phase
was used to calculate the rate of the enzyme-catalyzed
reaction. An extinction coefficient of 6.220 × 106 M-1
cm-1 for NADH was used for the indirect calculation of
the F1, 6BP production. The initial velocity (V0) of
NADH oxidation, without added substrate, was sub-
tracted from all activities measured. The initial reaction
rate is expressed as U/mg protein, with one U being
considered as the formation of 1 μmol F1, 6BP per mi-
nute. Protein concentration was measured by the Lowry
method [17], using BSA as a standard. A scan of the activ-
ity was performed in the pH range of 6.0 to 9.0 in order to
determine the optimum pH, which was in the range 8.0-
8.5. Nevertheless pH 7.4 was used as this was the pH that
was previously described to be the one where the enzyme
is most sensitive to allosteric regulation [8].
Kinetic and statistical analysis
The Kinetic parameters of maximal velocity (Vmax),
Hill’s coefficient (h), Kprime (K0.5^h) and the constant of
inhibition (Ki) for the substrate curves were calculated
by non-linear regression using the software Sigma-Plot
10 (Systat, CA, USA). Values are the mean ± standard er-
rors of the parameters, calculated by fitting the curves to
the previously described equations [8].
Sequence alignment
PFK sequences from several organisms were obtained
from NCBI (http://www.ncbi.nlm.nih.gov/protein/) [18].
Acession numbers: ORYCU-M XP_002723486; HOMSA-
M NP_001160159; ORYCU-C NP_001076217; MUSMU-
C NP_062677; AEDAE XP_001652300; CULPI XP_
001850333; ANOGA XP_564589; DROME NP_724891;
DROVI XP_002050868; DROPE XP_001361103; ACYPI
XP_001950251; TRICA XP_966779; PEDHU XP_0024
33151; BOMTE XP_012168289; 3o8L:A (PDB) and RPRC
RPRC011744 (Vector Base). Multi-sequence alignment
analysis was performed using Clustal W2 [19].
Molecular modeling of PFK
The 3D comparative models of A. aegypti and human
PFKs were constructed using the NCBI amino acid se-
quences with code numbers: NP_000280.1 (Homo sapi-
ens) and EAT41468.1 (A. aegypti). In the course of this
work, crystal structures of PFK from Pichia pastoris
(PDB ID 3OPY) and rabbit skeletal muscle (PDB ID
3O8L) were deposited in the Protein Data Bank [20–22].
Because of its high sequence similarity, the structure of
PFK from rabbit skeletal muscle seemed most suitable
for our structural analysis. PDB entry 3O8L was chosen
as the template for the construction of the 3D compara-
tive models of PFK, using the CPH models 3.2 server
(http://www.cbs.dtu.dk/services/CPHmodels/) [23]. In this
work, structural verification of the PFK models was per-
formed using the protein analysis tools in the Structural
Analysis and Verification Server (http://services.mbi.u-
cla.edu/SAVES/), which provides several tools for this pur-
pose, such as the Ramachandran plot and Verify 3D tools.
Visual inspections of the three-dimensional models were
made using PyMOL version 0.99 (http://www.pymol.org/).
Electrostatic potential calculations were performed with
PDB2QPR and APBS [24, 25] and volume calculations
were performed with Surfnet Tools available in the UCSF
Chimera software [26].
Docking Studies
The structure of AMP was extracted from the X-ray
structure of PFK from Pyrococcus horikoshii (PDB ID
3DRW) [27] and hydrogen atoms were added with Spar-
tan for Windows v.8 (Wavefunction Inc.). AMP geom-
etry optimization was done using the semi-empirical
method AM1 [28]. Chemscore_Kinase fitness function
available in GOLD docking software version 4.1.2 [29]
was used to score the docked AMP structures. The bind-
ing site was defined in the GOLD software as being all
atoms within a 10 Å radius from Lys475 or Lys487, in
the human or A. aegypti forms of PFK, respectively. The
protein-ligand complexes with the most favourable fit-
ness score values among the top scored complexes were
used for further visual inspection. During the automated
docking process, GOLD applies a flexible ligand docking
methodology in which stored conformations are posed
in the protein binding site, taking into account the full
acyclic flexibility and partial cycle flexibility.
Results and Discussion
Determination of optimum pH and Kinetic Parameters of
AaPFK
PFK is a well-studied enzyme, but its regulatory proper-
ties are not fully understood. Most of the research about
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its regulatory properties has been carried out in mam-
mals or in microorganisms, because of the ease of its
purification directly from these sources. Attempts to
purify active recombinant enzymes have often failed
due to the multimeric structure of the enzyme that
usually promotes its aggregation in an inactive form.
Also, this enzyme has catalytic activity only in its tetra-
meric form, having almost no activity as a dimer and
no detectable activity as a monomer. This aggregation
also hampers attempts to crystallize PFK and resolve
its crystal structure [21]. However, according to the au-
thor, a useful recombinant protein was only obtained
when the last 18 amino acids were removed. Neverthe-
less, recombinant mammalian PFK has recently been
crystallized [30].
Several studies with PFK in insect models have been
conducted [8, 31, 32]. In those studies, PFK activity was
measured under non-standardized conditions, making it
difficult to compare the results obtained by these au-
thors. Herein presented is the characterization of AaPFK
activity, measured using insect extracts.
First, the activity was measured at several pH values in
the range of 6.2 to 9.0. A bell-shape curve was obtained
(Fig. 1A) and AaPFK maximal activity was observed in
the pH 8-8.5 range. All other assays presented here were
performed at pH 7.4, as the objective was to measure
physiological PFK activity and this is the pH where allo-
steric regulation AaPFK is better evidenced (data not
shown).
The kinetic parameters of AaPFK were determined by
measuring the initial reaction rate as a function of sub-
strate concentration varying the concentrations of each
of the enzyme substrates, F6P and ATP, one at a time.
The initial reaction rate is expressed as U/mg protein,
with 1 U being the formation of one μmol F1, 6BP per
minute. Figures 1B and C show the saturation curves of
AaPFK by its substrates F6P and ATP, respectively. The
reaction rate shows cooperativity in F6P binding. The
experimental data were best fitted to the parameters of
the equation previously described [8] and were used to
assemble Table 1. The kinetic parameters obtained con-
firm that at concentrations above 2 mM, ATP becomes
a potent inhibitor of PFK activity. Table 1 indicates that
AaPFK has cooperativity towards F6P and ATP, as ex-
pected [8]. Assays at very low non-physiological ATP
concentrations would be necessary to corroborate the
cooperativity of this enzyme in this part of the saturation
curve. Because the aim of this work was to gain know-
ledge on the in vivo control of AaPFK, the enzyme was
not assayed at such low, non physiological ATP concen-
trations. Additionally, the assays were conducted using
crude enzyme preparations, which does not favour pre-
cise kinetic parameter determination, but allows better
in vivo conclusions.
Regulation of AaPFK by negative effectors
PFK is tightly regulated in all organisms. The rate of gly-
colysis is determined by a balance between the rate-
limiting reactions of the pathway towards sugar degrad-
ation and the rate of the reverse reactions. This balance is
the result of interactions of these enzymes with substrates
and several allosteric effectors.
Fig. 1 AaPFK activity as a function of pH (a), F6P (b) and ATP (c)
concentrations. The PFK activity of Aedes aegypti was measured in
the presence of 1 mM ATP and 1 mM F6P or at the concentrations
indicated, at pH 8.0 unless otherwise specified. Values are means ±
SEM of three independent experiments
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As shown in Fig. 1C, physiological concentrations of
ATP strongly inhibit AaPFK activity. Among the
known PFK inhibitors, citrate is known to enhance the
inhibitory effect of ATP on mammalian PFKs [3]. It
has been reported that citrate does not exhibit inhibi-
tory effects on insect PFKs. However, this lack of cit-
rate inhibition was never properly explained [6]. Even
30 years after this original finding, which has since
been extensively reported, no biochemical explanation
has been provided for the insensitivity of insect PFK to
citrate [3, 6, 7].
Here we show that AaPFK activity, at several sodium
citrate concentrations, exhibits no change in activity, ei-
ther in the presence of inhibitory ATP concentrations or
at non-inhibitory ATP concentrations (Table 2). Because
this extensively reported phenomenon remains unex-
plained, we investigated whether the lack of citrate effect
on insect PFK could be due to modifications in the cit-
rate binding site or by other structural changes in the
protein.
To study this hypothesis the AaPFK amino acid se-
quence was aligned to the PFK sequences from other
insects and to some mammalian sequences (Additional
file 1: Figure S1). As expected for insects, only one iso-
form of PFK was found in the A. aegypti proteome.
The amino acids that are essential for the interaction
of PFK with several ligands according to Kemp and
Gunasekera are marked [2]. The conservation of the
amino acids required for the citrate inhibitory effect
was examined (Additional file 1: Figure S1, symbol δ),
and only two changes were observed. First, Lys557
(human PFK numbering) is replaced by Arg in all of
the insect sequences examined, which is a conservative
substitution. Second, Lys617 (human PFK numbering),
an amino acid bearing a positively charged side chain,
is replaced by either Ser or Ala, neutral amino acids, in
all insect sequences examined (Fig. 2A, symbol δ).
Near this substitution, a neutral Threonine (Thr618 -
human PFK numbering) in mammals is substituted by
a negatively charged residue in all insects (Glu or Asp)
(Fig. 2A). Taken together, these substitutions could be
partially responsible for the lower affinity of the
negatively charged citrate molecule for the protein
binding site, rendering the enzyme insensitive to cit-
rate inhibition.
It is also known that citrate does not bind to mamma-
lian PFK if the last 30 amino acids of its sequence are re-
moved by enzymatic proteolysis [3, 33]. Fig. 2 shows the
alignment of the carboxyl terminal region of several
PFKs. A high conservation of amino acid sequence is
found in animal PFKs. Nevertheless, the high conserva-
tion of the insect carboxyl-terminal region amongst in-
sects is different from that of vertebrates. In insects, this
region is characterized by a high number of negatively
charged amino acids (Fig. 2B). Martínez-Costa et al.
have also shown [3] that replacing Leu767 and Glu768
of the M-type isoform of human PFK (PFK-M) with gly-
cine prevents citrate from binding to the enzyme. Al-
though these residues have never been implicated in
citrate binding to the enzyme, their relevance to citrate
inhibitory effect was demonstrated. It is possible that
these residues are important to guide the binding of cit-
rate into PFK. These residues are not conserved in insect
PFKs (Fig. 2B), which could be an additional reason for
its insensitivity to citrate regulation.
The highly negatively charged C-terminal terminus
found in insects may explain why correct guidance of
citrate by this region of the insect protein is unlikely.
This hypothesis would be supported if the 3D structure
of the protein indicates that these residues are involved
in correct binding. Unfortunately, 3D comparative mod-
eling of the C-terminal tail is not possible at this time
because of a lack of template. Until recently, there was
no 3D structure of a eukaryotic PFK available as a tem-
plate for citrate docking analysis, except for Trypano-
soma brucei, which has only 487 amino acid residues
and lacks the residues in question. In 2011, a crystal
structure of PFK from rabbit skeletal muscle (PDB code
3O8L) [21] was deposited into the PDB. Unfortunately,
the recombinant form of that enzyme is missing the final
18 amino acids. Nevertheless, the C-terminal residues in
the crystallized protein show that the C-terminal tail is
Table 1 Kinetic parameters of Aedes aegypti PFK upon addition
of its substrates F6P and ATP
F6P ATP
Parameter Activity [U (mg protein) -1] Activity [U (mg protein) -1]
Vmax 4.741 ± 0.1462 4.727 ± 0.568
h 2.798 ± 0.3939 0.741 ± 0.203
Kprime 1.485 ± 0.2192 0.429 ± 0.100
Ki ——— 4.536 ± 0.178
PFK activity was measured at pH = 7.4, F6P and ATP range 0.1–8.0 mM. Kinetic
parameters for the substrate curves were calculated by non-linear regression
using the software Sigma-Plot 10 (Systat, CA, USA). Values are the mean ± SEM.
Data from three independent experiments were used to fit through the
equations described in the Methods. Vmax - maximal velocity; h – Hill’s
coeficient; Kprime – K0.5^h, Ki – constant of inhibition
Table 2 Effect of citrate on Aedes aegypti PFK activity
Citrate (mM) Activity [U (mg protein) -1]
ATP (1 mM) ATP (5 mM)
0 4.02 ± 0.26 2.50 ± 0.13
0.25-8.0 4.01 ± 0.40 2.44 ± 0.19
PFK activity was measured at pH = 7.4, 1 mM F6P at low and high ATP
concentrations, without (first row) and with added citrate. The assay was
conducted at eight different citrate concentrations in the range of 0.25 – 8 mM.
Values are means ± SEM of four independent experiments
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very close to the pocket where citrate binds (Fig. 3). Very
recently, other mammalian crystal structure of PFK were
published, including the one from human platelets [30],
which has some differences from the muscle, so it was
not used in this work. Altogether these observations
reinforce our proposition that the negative nature of the
carboxy terminus of insect PFKs is one of, if not the
major, cause for its insensitivity to citrate.
This C-terminal extension of the mammalian enzyme,
when compared to the bacterial enzyme, [33] seems to
have evolved in order to provide mammals with this
control, which is essential for coordinating carbohydrate
and fatty acid metabolism. In mammals, the presence of
citrate in the cytoplasm, where glycolysis occurs, indi-
cates that fatty acid synthesis is underway. To make this
possible, the cell must have fulfilled its ATP require-
ments, whilst still having excess carbon building blocks
available that cannot be incorporated into glycogen.
When this excess ATP is observed, respiration slows
down and NADH concentrations inside the mitochon-
dria rise, which inhibits isocitrate dehydrogenase. This
slows the citric acid cycle and allows citrate concentra-
tions to build up inside the mitochondria, causing citrate
to be pumped out to the cytoplasm. Citrate does not ac-
cumulate in the cytoplasm, but is readily converted to
acetyl-CoA and oxaloacetate by citrate lyase and supplies
the carbon source for fatty acid biosynthesis. The cyto-
plasmic levels of citrate build up in the cytoplasm and
inhibit PFK only if the products of cytoplasmic citrate
lyase are not rapidly consumed [34, 35]. It seems that
this control is not as essential in insects because sugar is
their major food source, including females from anauto-
genous species. Thus, these animals need to perform gly-
colysis and fatty acid synthesis at the same time. In the
case of female mosquitoes, part of the sugar ingested be-
fore a blood meal is converted to lipid that accumulates in
oocytes. This lipid accumulation minimizes follicular re-
absorption, thus increasing the fertility rate [36].
Regulation of AaPFK by positive effectors
F2, 6BP is one of the most potent activators of PFK. As
expected, F2, 6BP activated AaPFK even at a concentra-
tion of ATP (1 mM) that is not inhibitory (Additional
file 2: Figure S2). The activation factor shown for F2,
6BP is lower than the one described for other organ-
isms [5]. This is probably due to the fact that the en-
zyme was not purified prior to the assay, so the
Fig. 2 Alignment of amino acid sequences for the citrate binding site of several PFKs. The putative residues assigned to the binding of citrate
and in the vicinity of this site where the greatest differences are observed are indicated by δ. The sequences shown are from: Oryctolagus
cuniculus (ORYCU), Mus musculus (MUSMU), Homo sapiens (HOMSA), Aedes aegypti, (AEDAE), Culex quinquefasciatus (CULPI), Anopheles gambiae,
ANOGA), Drosophila melanogaser (DROME), Drosophila virilis (DROVI), Drosophila pseudoobscura (DROPE), Acyrthosiphon pisum, (ACYPI), Tribolium
castaneum, (TRICA), Pediculus humanus corporis (PEDHU), Bombus terretris (BOMTE), Rhodnius prolixus (RPRC)
Fig. 3 3D representation of rabbit PFK-M. Molecular surface
representations of rabbit skeletal muscle PFK (PDB ID 3O8L) emphasizing
the citrate binding site (red) and the last 12 amino acids in the
C-terminal tail (yellow)
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presence of some endogenous F2, 6BP could mask its
effect, as F2, 6BP activates PFK at concentrations below
1 μM. Furthermore, some 6-phosphofructo-2-kinase/
fructose-2,6-bisphosphatase-like activity must be present
in the homogenate, and the conversion of added F6P to
F2, 6BP is likely to occur because both enzymes share the
same substrates.
Another well-known effector of PFK is AMP. The ef-
fect of AMP as an allosteric activator of vertebrate PFK
is undisputable [34]. In insects, this effect has only been
reported in bees and kissing bugs [8, 37]. Besides these
reports, no other references regarding AMP affecting
PFK kinetic properties in insects were found. A specific
region of PFKs close to residues Glu485, Gly486 and
Lys487 (AaPFK numbering) have been reported as being
important for AMP binding and activation of PFK in
mammals [2]. In order to see if there is an alteration in
the corresponding residues in A. aegypti and other insects,
the sequences from several organisms were aligned to the
one described by Kemp and Gunasekera [2] (Additional
file 1: Figure S1). There is at least one spot assigned to
AMP binding in mammals that is modified in AaPFK and
also in all other known dipteran PFK sequences examined.
This substitution is not present in the sequences of PFKs
from other orders of insects but Hymenoptera. Figure 4
shows in more detail the substitutions in the AMP bind-
ing site of the human 475 and 476 positively charged ly-
sine residues by glutamic acid and glycine in AaPFK.
These replacements cause a profound change in the
electrostatic properties of the AMP binding site. The
resulting negative local charge could repel AMP, a
negatively charged molecule, preventing AMP from
docking at this site.
The comparative analysis of protein sequences using
clustalW2 algorithm is very informative in what con-
cerns phylogenetic relations among organisms. Also, it
can be helpful to raise the working hypothesis about the
effect of observed sequence differences on protein prop-
erties. On the other hand, speculations about the effects
of the observed differences on actual spatial interactions
among amino acid substitutions, even more when they
are apart in the linear sequence, are not very reliable
and remain only as speculations. The crystal structure of
proteins gives reliable information on spatial relation-
ships of amino acids and about pockets, binding sites
and also about the electrostatic potential of protein sur-
face. On the other hand protein crystallization and x-ray
structure determination remain expensive and technic-
ally difficult. Because of that, protein modeling and
docking studies became more and more accepted as a
method to study protein-ligand interactions. To further
test if the hypothesis that the ability of AMP binding to
its regulatory site in PFK from different sources of pro-
teins is determined by differences in local charges,
experiments of 3D molecular modeling and docking
were performed as described in the methods, although
we are aware of the limitations of their use in docking
studies.
PFK of the insects Rhodnius prolixus and Bombus
atratus PFK must be included in this study because it
was previously shown both are stimulated by AMP
[37]. However, we use Bombus terrestris PFK se-
quence, a closely related species, instead of Bombus
atratus because it does not have its PFK sequence de-
posited in any databank. It is interesting to see in the
alignment of several PFKs that B. terrestris PFKs have
peculiarities in the region of AMP binding (Fig. 4).
The consequences of this sequence change in the elec-
trostatic potential of the local protein surface caused
by aspartic acid residues will be better examined in a
3D model. It can be seen in Fig. 5A that AMP suc-
ceeds in binding B. terrestris PFK. It binds close to the
amino acid residues that form the triad Glu498,
Glu499 and Gln500, and positively charged amino acid
Fig. 4 Alignment of amino acid sequences of the AMP binding site
of several PFKs. The putative residue assigned to the binding of AMP
and its vicinity is indicated by ϕ. The sequences shown are from:
Oryctolagus cuniculus (ORYCU), Mus musculus (MUSMU), Homo sapiens
(HOMSA), Aedes aegypti, (AEDAE), Culex quinquefasciatus (CULPI),
Anopheles gambiae, ANOGA), Drosophila melanogaser (DROME),
Drosophila virilis (DROVI), Drosophila pseudoobscura (DROPE),
Acyrthosiphon pisum, (ACYPI), Tribolium castaneum, (TRICA), Pediculus
humanus corporis (PEDHU), Bombus terretris (BOMTE), Rhodnius
prolixus (RPRC)
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residues Lys497 and Arg759, in the vicinity. The hy-
droxyl groups from the adenine ring are involved in a
hydrogen bonding network with the main-chain amino
group of Pro495 and Glu498, with one of the oxygen
atoms of the side chain of Glu499 and with the amide
group of the side chain of Gln500 (Fig. 5B). Addition-
ally, the anionic phosphate group performs an ionic
interaction with Arg759 (Fig. 5B). Altogether, it seems
that AMP binding is favoured, since the electrostatic
map suggests that, overall, there is enough positive
charge at the surface of the protein to counterbalance
point negative charges and allow AMP binding and
exert stimulatory effects in bombus PFK. To further
analyse this explanation, models and docking experi-
ments were performed with other insect PFKs besides
B. terrestris and human PFK (Fig. 5C-G). The hypoth-
esis of the importance of the electrostatic potential of
protein surface at this site to the AMP binding is rein-
forced as the same could be used to explain the other
PFKs analysed.
The apparent insensitivity of AaPFK and D. melanoga-
ster PFK to AMP de-inhibition, suggested by Fig. 5C-D,
has not been reported previously. Then, we analysed
whether this modified PFK regulatory mechanism was
actually shared by other dipteran PFKs. As Culex quin-
quefasciatus (vector of Filariasis) and Anopheles aquasa-
lis (vector of Malaria) are important disease vectors, any
control strategy developed for A. aegypti might be ap-
plicable to these species also. The PFK activity experi-
ment was expanded to assay the effect of AMP on the
PFK activity of C. quinquefasciatus, A. aquasalis and
Drosophila melanogaster (an organism considered a
model) besides A. aegypti. The results presented in
Table 3 show that, in all dipterans tested, AMP does not
activate PFK, even at inhibitory ATP concentrations.
This result reinforces the hypothesis that the negative
charge introduced in the putative AMP binding site by
the replacement of a glycine by a glutamate could in fact
cause those PFKs to be insensitive to AMP. To explain
this result, the hypothesis that the lack of an effect of
Fig. 5 Docking of AMP and Electrostatic surface models. Relevant amino acids to catalysis or AMP stabilization at this pocket are highlighted.
Yellow dotted lines in panel B represent the hydrogen bonds and ionic interactions
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AMP on AaPFK could be related to changes in the AMP
binding site was investigated in more detail.
In order to suggest an explanation for the putative
inability of AMP to bind to AaPFK, but successfully
bind to human and bumblebee PFK, comparative mo-
lecular modeling and docking studies using the pre-
dicted models of Human and A. aegypti PFK were
performed.
Superimposition of the models of human and AaPFKs
(Fig. 6) showed an RMSD of 0.4 Å, which is a very good
fit their degree of similarity is considered.
A visual inspection of the docking models shows that
when the corresponding amino acid residues Glu485
and Lys475 were used as reference sites for docking
with A. aegypti and human PFK, respectively, the puta-
tive observed binding modes are quite different, des-
pite the fitness score values being close (6.99 and 10.09
for A. aegypti and human PFKs, respectively) (Fig. 7).
The top scored model obtained for AMP and AaPFK
places the ribose ring close to Gly486 and Leu483. The
hydroxyl groups form a network of hydrogen bonds
between the main-chain amino group of Gly486 and
the carbonyl group of Leu483. The adenine ring hydro-
gen bonds to the main-chain amino group of Leu483
(Fig. 6A). The phosphate group, however, was oriented
towards the outer part of the binding site, pointing to-
wards the protein solvent-accessible surface. This is a
reasonable result because the increased charge density
in the putative allosteric AMP binding pocket, caused
by the Lys-Glu change from human to AaPFK, is most
likely responsible for a better fit of the basic adenosine
ring. Additionally, when the best docking model ob-
tained for AMP and human PFK was inspected, the
binding mode was inverted in relation to the model
obtained with AaPFK. In this case, the adenine ring
and the sugar moiety hydrogen bond to Lys476 and
Leu474 (Fig. 7B). Again, the presence of basic residues
in the triad offers a better electrostatic environment
for the anionic phosphate group. It fits in a cavity near
and, opposite to, the Lys-Lys-Ser triad, forming an
ionic interaction with Arg472 most likely due to a
“closed” conformation adopted by Lys476 and Lys477
(Fig. 7B). Finally, there appears to be more room for
AMP binding in the human enzyme. The difference
in the accommodation of AMP in both PFKs struc-
tures led to the calculation of the volume of putative
ligand pockets in both enzymes. The comparable
pockets comprise Glu485 and Lys475, amongst other
amino acid residues (Additional file 3: Figure S3). A.
aegypti and human PFKs, have volume values of 64.2
and 117.7 Å3, respectively. This result corroborates
what has been suggested by our docking studies and
supports the different binding models observed in
both PFKs.
Table 3 Effects of AMP on PFK activity in Diptera
A MP (μM) Activity [U (mg protein) -1]
Aedes aegypti Culex quinquefasciatus Anopheles aquasalis Drosophila melanogaster
0 4.00 ± 0.09 4.36 ± 0.93 5.33 ± 1.19 0.19 ± 0.02
1-1000 3.92 ± 0.21 4.36 ± 0.16 4.79 ± 0.75 0.11 ± 0.05
PFK activity was measured at pH = 7.4, 1 mM F6P, 1 mM ATP with and without (first row) added AMP. The assays were conducted at eight different AMP concentrations
in the range of 1-1000 μM. Values are means ± SEM of three independent experiments
Fig. 6 Superimposition of Aedes aegypti (blue) and Homo sapiens (purple) PFK models focusing on the AMP binding site. The square marks AMP
binding site. Relevant amino acids are highlighted (b) and (c)
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Conclusions
Dipterans are the most important vectors of the most
rapidly spreading diseases around the world. This fact
relies especially on the efficient ability of these animals
to disperse by flying, which is an action with a high de-
mand for carbohydrate fuel. Here we provide the first
study about the unique regulatory mechanism of PFK in
flying insects, one of the rate-limiting enzymes of glyco-
lytic flux. By sequence alignment and modeling of dip-
teran PFKs we propose relevant explanations to their
insensitivity to well known effectors, AMP and citrate. A
property difference in a key enzyme of a central pathway
that has the potential to be targeted by a novel insecti-
cide with the aim to control diseases transmitted by
these arthropod vectors was unveiled.
Additional files
Additional file 1: Figure S1. Alignment of the amino acid sequences
of several insects and mammalian PFKs. The putative residues assigned to
the binding of effectors/substrates are indicated. α - F6P; β - ATP substrate;
χ - ATP inhibitor; δ - citrate; ε - F2, 6BP ϕ - AMP. The sequences shown are
from: Oryctolagus cuniculus (ORYCU), Mus musculus (MUSMU), Homo sapiens
(HOMSA), Aedes aegypti, (AEDAE), Culex quinquefasciatus (CULPI), Anopheles
gambiae, ANOGA), Drosophila melanogaser (DROME), Drosophila virilis
(DROVI), Drosophila pseudoobscura (DROPE), Acyrthosiphon pisum, (ACYPI),
Tribolium castaneum, (TRICA), Pediculus humanus corporis (PEDHU), Bombus
terretris (BOMTE), Rhodnius prolixus (RPRC). (TIF 9895 kb)
Additional file 2: Figure S2. Effect of F2, 6BP on Aedes aegypti PFK
activity. PFK activity was measured at pH = 7.4, 1 mM F6P, 5 mM ATP at
several F2, 6BP concentrations (0.01–50 μM). Values are the means ± SEM
of three independent experiments. (TIF 466 kb)
Additional file 3: Figure S3. The electrostatic surface of Aedes aegypti
(A) and Homo sapiens (B) PFK models. Red and blue are negatively and
positively charged areas respectively. Arrows indicate the entry of the
AMP binding pocket. (TIF 955 kb)
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